彭剑青，博士，副教授，青年博士生导师。目前主持国家自然科学项目1项、人力资源社会保障部高层次留学人才回国资助项目1项、贵州省科技厅基金项目2项，贵州医科大学优秀青年拔尖人才项目和博士启动基金项目各1项；已完成多项省级、市厅级项目结题验收。以第一或通讯作者在Journal of controlled release、Journal of Nanobiotechnology、Frontiers in Pharmacology、International Journal of Pharmaceutics等国际重要学术期刊发表13篇SCI论文，其中2篇影响因子大于10分。

研究领域：

• 联合给药纳米递送平台开发与评价

• 药物组合体内分布时空同步性研究

• 中药肺部给药制剂开发与评价

主持项目：

1. 构建“三联疗法”纳米杂化体系用于结肠癌治疗的研究（黔科合基础-ZK[2021]一般552，2021/04-2024/04，在研，主持）。

2. 人力资源社会保障部高层次留学人才回国工作资助（2020年）（RSBLXHGZ202001号，2020/12-2023/12，在研，主持）。

3. 贵州医科大学优秀青年人才培养计划-青年拔尖人才（贵医大优秀青年人才 (2020)102号，2020/06-2025/06，在研，主持）。

4. 基于ROS自增强的双敏感递送系统联合自噬抑制用于抗结肠癌增殖和转移（国家自然科学基金地区科学基金项目，81960647，2020/01-2023/12，在研，主持）。

5. ROS扩增型pH敏感纳米粒用于提高青蒿素抗肿瘤作用的研究（黔科合基础 [2019]1255号，2019/01-2021/12，已结题，主持）。

6. 壳聚糖包裹的1,8-桉叶油醇脂质纳米粒用于血管内皮损伤保护的研究（院博合J字 [2018]006号，2019/01-2021/12，已结题，主持）

7. 利用ROS信号扩增型纳米递药系统提高青蒿素抗肿瘤作用的研究（QZYY-2018-093号，2018/07-2019/07，已结题，主持）。

代表性著作：

1. Jianqing Peng^#, Zimin Cai^#, Qin Wang^#, Jia Zhou, Jinzhuan Xu, Di Pan, Tingting Chen, Guangqiong Zhang, Ling Tao, Yi Chen* and Xiangchun Shen*. Carboxymethyl Chitosan Modified Oxymatrine Liposomes for the Alleviation of Emphysema in Mice via Pulmonary Administration. Molecules, 2022, 27, 3610.

2. Zimin Cai^#, Qin Wang^#, Jinzhuan Xu, Jia Zhou, Zhaohui Jiang, Di Pan, Yanyan Zhang, Ling Tao, Jianqing Peng*, Yi Chen*, Xiangchun Shen*. Enhanced protective activity of 1,8-cineole on emphysema using hyaluronic acid-coated liposomes via quantitative pulmonary administration in mice, Journal of Drug Delivery Science and Technology, 2022, 72, 103402.

3. Jianqing Peng, Qin Wang, Jia Zhou, Shuli Zhao, Pan Di, Yan Chen, Ling Tao, Qianming Du* Xiangchun Shen* and Yi Chen*. Targeted lipid nanoparticles encapsulating dihydroartemisinin and chloroquine phosphate for suppressing the proliferation and liver metastasis of colorectal cancer. Frontiers in Pharmacology, 2021; 12: 720777.

4. Chen Yi^#, Jiang Zhaohui^#, Xu Jinzhuan, Zhang Jiyuan, Sun Runbin, Zhou Jia, Lu Yuan, Gong Zipeng, Huang Jing, Shen Xiangchun, Du Qianming*, Peng Jianqing*. Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice. Journal of Nanobiotechnology, 2021, 19: 230. (IF > 10)

5. Jianqing Peng^#, Zhaohui Jiang^#, Guoping Wu^#, Zimin Cai, Qianming Du, Ling Tao, Yanyan Zhang, Yi Chen*, Xiangchun Shen*. Improving protection effects of eucalyptol via carboxymethyl chitosan-coated lipid nanoparticles on hyperglycaemia-induced vascular endothelial injury in rats. Journal of Drug Targeting, 2021, 29: 520-530.

6. Zi-Min Cai, Jian-Qing Peng*, Yi Chen, Ling Tao, Yan-Yan Zhang, Ling-Yun Fu, Qing-De Long, Xiang-Chun Shen*, 1,8-Cineole: a review of source, biological activities, and application. Journal of Asian Natural Products Research, 2021, 23(10): 938–954.

7. Yi Chen^#, Qianming Du^#, Ying Zou, Qianqian Guo, Jing Huang, Ling Tao, Xiangchun Shen*, Jianqing Peng*. Co-delivery of doxorubicin and epacadostat via heparin coated pH-sensitive liposomes to suppress the lung metastasis of melanoma. International Journal of Pharmaceutics, 2020, 584, 119446.

8. Jianqing Peng, Shintaro Fumoto⁎, Tadaharu Suga, Hirotaka Miyamoto, Naotaka Kuroda, Shigeru Kawakami, Koyo Nishida. Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles, Journal of Controlled Release, 2019, 302:42-53. (IF > 10)

9. Yi Chen#, Qianming Du#, Qianqian Guo, Jing Huang, Lina Liu, Xiangchun Shen*, Jianqing Peng*. A W/O emulsion mediated film dispersion method for curcumin encapsulated pH-sensitive liposomes in the colon tumor treatment. Drug Development and Industrial Pharmacy, 2019, 45(2): 282-291.

10. Jianqing Peng, Shintaro Fumoto*, Hirotaka Miyamoto, Yi Chen, Naotaka Kuroda, Koyo Nishida. One-step formation of lipid-polyacrylic acid-calcium carbonate nanoparticles for co-delivery of doxorubicin and curcumin. Journal of Drug Targeting, 2017, 25(8): 1-11.

11. Jianqing Peng^#, Xiaole Qi^#, Yi Chen, Ning Ma, Ziwei Zhang, Jiaxu Xing, Xuehua Zhu, Zhengrong Li*, Zhenghong Wu*. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells. Journal of Drug Targeting, 2014, 22(5): 428-438.

12. Jianqing Peng#, Wen Zhou#, Xinyi Xia#, Xiaole Qi, Luan Sun, Min Wang, Zhenghong Wu*, Zhengrong Li*. Encapsulation of Acetylshikonin by Polyamidoamine Dendrimers for Preparing Prominent Nanoparticles. AAPS PharmSciTech, 2014, 15(2): 425-433.

13. Jianqing Peng, Zhenghong Wu*, Xiaole Qi, Yi Chen, Xiangbo Li. Dendrimers as potential therapeutic tools in HIV inhibition. Molecules, 2013, 18(7): 7912-7929.

联系方式：

Tel：17684202475，E-mail: pengjianqing90@126.com

地址：贵州省贵阳市花溪区贵州医科大学格物楼B5-10。